mixed-effects logistic regression model xtlogit Search Results


dexmedetomidine  (STATA Corporation)
99
STATA Corporation dexmedetomidine
Mean data of all individual ECT sessions (mean ± SD)
Dexmedetomidine, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mixed-effects+logistic+regression+model+xtlogit/pmc05449135-89-7-28?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
dexmedetomidine - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Mean data of all individual ECT sessions (mean ± SD)

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Mean data of all individual ECT sessions (mean ± SD)

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques:

Mean data per patient with and without dexmedetomidine use

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Mean data per patient with and without dexmedetomidine use

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques:

Multivariate repeated measurement logistic regression analysis for prediction of PIA occurrence

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Multivariate repeated measurement logistic regression analysis for prediction of PIA occurrence

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques:

Multivariate repeated measurement logistic regression analysis for prediction of a maximum heart rate >130 bpm

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Multivariate repeated measurement logistic regression analysis for prediction of a maximum heart rate >130 bpm

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques:

Multivariate repeated measurement logistic regression analysis for prediction of urapidil administration

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Multivariate repeated measurement logistic regression analysis for prediction of urapidil administration

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques:

Multivariate repeated measurement logistic regression analysis for prediction of a systolic blood pressure rise >20 mmHg

Journal: Neuropsychiatric Disease and Treatment

Article Title: Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

doi: 10.2147/NDT.S134751

Figure Lengend Snippet: Multivariate repeated measurement logistic regression analysis for prediction of a systolic blood pressure rise >20 mmHg

Article Snippet: To test the hypothesis that use of dexmedetomidine predicts the non-occurrence of PIA, we used a multivariate repeated measurement logistic regression analysis (ie, multilevel mixed-effects logistic regression using STATA 11 “xtlogit”) – with occurrence of PIA as dependent variable and dexmedetomidine use, age, stimulation dose, dose of S-ketamine and electrode placement as independent variables.

Techniques: